News

Intel ( INTC -0.70%) was once a reliable blue chip stalwart for long-term investors. As the world's largest manufacturer of ...
US stocks managed to eke out gains on Monday as bond yields eased off bigger gains and Wall Street largely shrugged off Moody ...
US stocks retreated on Monday while Treasury yields rose as Wall Street processed Moody's downgrade of the US credit rating ...
US stocks came back from steep losses on Monday as Wall Street shrugged off Moody's downgrade of the US credit rating and ...
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments.